Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CALHM1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA553779
Description
Immunogen sequence: CTEHAKAFAK VCIQQFFEAM NHDLELGHTH GTLATAPASA AAPTTPDGAE EEREKLRGIT DQGTMNRLLT SWHKCKPPLR LGQEEPPLMG NGW Highest antigen sequence identity to the following orthologs: Mouse - 82%, Rat - 80%.
Alzheimers disease (AD) is a progressive neurodegenerative disorder characterized by a massive loss of neurons in several brain regions and by the presence of senile plaques comprised of aggregated amyloid-beta (Abeta) peptides produced by the endoproteolysis of the amyloid precursor protein (APP). The calcium homeostasis modulator 1 (CALHM1) is a recently identified multipass transmembrane glycoprotein that controls cytosolic Ca2+ concentration and Abeta levels. While some studies suggest CALHM1 is significantly associated with risk of AD, other reports suggest there is no link. CALHM1 has been suggested to modulate the Ca2+-dependent proteolytic process of APP through controlling the level of cytosolic Ca2+.
Specifications
CALHM1 | |
Polyclonal | |
Unconjugated | |
Calhm1 | |
calcium homeostasis modulator 1; calcium homeostasis modulator protein 1; Calhm1; EG546729; Fam26c; family with sequence similarity 26, member C; Protein FAM26C; RGD1564891 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
255022 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q8IU99 | |
Calhm1 | |
Recombinant protein corresponding to Human CALHM1. Recombinant protein control fragment (Product #RP-91132). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction